Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
about
The Raji cell radioimmune assay for detecting immune complexes in human seraHuman complement component C3: cDNA coding sequence and derived primary structureC3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblastInteraction of beta1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on bindingUsing animal models to determine the significance of complement activation in Alzheimer's diseaseExpression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis.Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibitionStructures of complement component C3 provide insights into the function and evolution of immunityPolymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factorDynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometryMeningococcal infection and proteolytic controlContinuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.Complement-derived leukotactic factors in inflammatory synovial fluids of humans.C1r, subunit of the first complement component: purification, properties, and assay based on its linking role.Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors.Chemotropism indices for polymorphonuclear leukocytes.Serum-free culture of hamster lymphoid cells and differential inhibition of lipopolysaccharide stimulation by isologous serum.Further characterization of a factor from endotoxin-treated serum which releases histamine and heparin from mast cellsComplement activation by whole endotoxin is blocked by a monoclonal antibody to factor BCell and tissue damage through antigen-antibody complexesThird component of complement (C3): structural properties in relation to functionsComplement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5aPlatelets, fibroblasts, and inflammation: tissue reactions to platelets injected subcutaneouslyThe effect of complement depletion on wound healing.Leukotaxis and leukotactic disorders. A reviewAcute inflammation. A review.Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cellsGross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man.Specific and nonspecific channels leading to proteolysis in antibody preparationsIdentification of C3 beta chain as the human serum eosinophil cytotoxicity inhibitor.C3 leukotactic factors produced by a tissue protease.Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets.The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats.The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3xReceptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
P2860
Q24563492-B98706BC-2A3B-4962-881D-04A6AA8D89D3Q24568206-A82ED4AD-BFBD-4B91-84BB-8D75FCAC4C27Q24680329-225E9FA7-3641-4D36-8F85-D5BF5522A6ADQ24684253-1EC69176-230A-4B51-971E-C367B09A7C8EQ24796236-6A9E1EF9-8CBC-4E04-BE1F-4C4A5BE63525Q24801467-D1B3DD08-5662-4337-ABDE-1B4347F416E3Q27647015-080D85AA-EEFA-4B68-9B6F-02C996565555Q28273530-C88A3EC5-615E-4880-A840-B723B0870525Q28303590-C958FA4C-A3DF-41EE-9CB8-67DC1FC62A52Q33331674-60BBB654-254E-49B2-9FE2-22630215DF3CQ33846778-614E4D2A-64FB-47E8-9C16-A0A408D81CCFQ34057909-F303E112-7768-4D12-B376-DB8BAB2BB803Q34058258-2F9090F3-28D5-41FB-9653-EFFF0C0E0235Q34059513-89C399B1-8B93-4C76-93AF-F6B2AB904FD4Q34110927-FEEB6C84-C148-49CB-AAFC-5DF581647F0AQ34271708-B2BAB8D2-F0DE-474D-A15E-1C45D9848084Q34402276-891CFDD7-C753-4D1C-A7AE-44F1BC2D96CBQ34473991-16A4F192-B004-4329-8181-9B79215FF0B3Q34541798-33C0AE79-F236-4057-8585-95757036214CQ34775664-8F986B60-0443-42CD-96C9-FAAB1C04F3B8Q35080082-197CE0BD-DC15-4469-B26F-A4FB2862A2DAQ35194351-04E04EEA-6BFA-430A-A766-D203E5204F24Q35207230-CA961BE9-1418-4C44-A3E8-7189B8C1A698Q35332849-14CFADB4-89CD-4BD0-AE22-D5B6C0F1D04CQ35863059-3F8CC57F-E444-4EFA-B6C3-E256F35C81FDQ35875265-7B4FD4CB-49D0-4C21-9D51-D39FD8BA6C39Q35875620-5D52B959-8EA9-424F-9DDF-7F25F5CC7288Q36076876-287763E1-D8ED-473B-AA4A-C12401CA24D1Q36092712-5B5F9C80-5B65-4FD2-BD1A-B9C65D330168Q36101293-1CB4DBC0-2844-44EB-971F-7B438B017F74Q36130513-D8B050DD-0B0E-4D18-97FA-1BB4D3008669Q36230493-D8E795D1-1097-43EF-A91A-A9A3E5AFA0ECQ36269901-CB2F482F-E693-4FC3-B370-2E2F488839FDQ36270397-809F52A0-3644-4D33-BAF2-51646F000DF7Q36270809-9FC1D404-DC35-4FCD-9F40-9602ADA14855Q36270882-35BBAE82-B550-4A3F-BF66-3F0882F7E19DQ36271257-559C0CD0-02EA-4676-BF10-82C064A04205Q36272983-19F05009-D623-44B7-AB1B-E1C39F1EAA6EQ36273277-3A1D7CC5-7511-4862-9B44-2F15F79BC304Q36273333-592094D2-2F96-434F-981B-4D8765CBFFA4
P2860
Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh
1969年學術文章
@zh-hant
name
Isolation of a fragment (C3a) ...... in inactivator of human serum.
@ast
Isolation of a fragment (C3a) ...... in inactivator of human serum.
@en
type
label
Isolation of a fragment (C3a) ...... in inactivator of human serum.
@ast
Isolation of a fragment (C3a) ...... in inactivator of human serum.
@en
prefLabel
Isolation of a fragment (C3a) ...... in inactivator of human serum.
@ast
Isolation of a fragment (C3a) ...... in inactivator of human serum.
@en
P2093
P2860
P356
P1476
Isolation of a fragment (C3a) ...... in inactivator of human serum.
@en
P2093
C G Cochrane
H J Müller-Eberhard
V A Bokisch
P2860
P304
P356
10.1084/JEM.129.5.1109
P407
P577
1969-05-01T00:00:00Z